Shanghai, China, 11 April 2025 – At the 91st China International Medical Equipment Fair (CMEF), MicroPort® and its 16 affiliates presented over 80 advanced innovations across eight major body systems, showcasing the depth and diversity of the Group’s portfolio.
Among the highlights was the MT-4000, the latest model of the Toumai® multi-port laparoscopic surgical robot developed by MicroPort® MedBot™, which features the industry’s pioneering full-spectrum fluorescence imaging system and advanced automation features for intelligent surgery. Firesorb®, the world’s latest-generation fully bioresorbable cardiac stent, marked a significant milestone in cardiovascular innovation. Also featured was VitaFlow Liberty® Flex, the only coaxial steering, self-expanding TAVI delivery system currently available.
These groundbreaking technologies embody MicroPort®’s integrated platform of device + imaging + therapy, developed to meet the increasing clinical needs needs across various fields, including cardiovascular, respiratory, imaging, and surgical care.
In 2024, MicroPort® achieved a series of major regulatory milestones, obtaining 307 first-time approvals across 44 countries and regions. The Group’s solutions are now deployed in over 20,000 healthcare institutions worldwide, providing care for more than 200 disease areas.
To enhance global accessibility and foster co-innovation, MicroPort® has established the “GloMatrix™” ecosystem for international markets. This platform strengthens clinical translation and supports collaborative development with hospitals, distributors, and strategic partners worldwide.
About MicroPort®
Founded in 1998 on the belief that every person has the right to high quality medical treatments, MicroPort® (MicroPort Scientific Corporation; HKEX: 00853) is a global medical devices company. MicroPort® provides solutions across twelve therapeutic areas, including cardiovascular, orthopedics, cardiac rhythm management, electrophysiology, endovascular, neurovascular and surgical robotics among others. For over 26 years, MicroPort® has been breaking barriers and accelerating access to life-changing solutions so that patients everywhere can continue living better and longer lives. With therapeutic solutions that are available in more than 100 countries and over 20,000 hospitals around the world, today, every 5 seconds a patient around the world benefits from a MicroPort® life-changing solution.
More information is available at: www.microport.com